Literature DB >> 26398064

Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries.

Linus Chuang1, Margaux J Kanis, Brigitte Miller, Jason Wright, William Small, William Creasman.   

Abstract

OBJECTIVE: To summarize the literature on options of management of patients treated for locally advanced cervical cancers with a specific focus on resource-constrained settings where brachytherapy is not available.
MATERIALS AND METHODS: A Medline search was performed to summarize studies about treatment approaches including neoadjuvant chemotherapy, primary surgery for bulky cervical cancer, and chemoradiation followed by surgery. Summaries are by treatment approaches that are relevant to resource-constrained settings.
RESULTS: There are a lack of studies performed on neoadjuvant chemotherapy in low-resource settings. Primary surgery followed by chemoradiation therapy for selected patients with bulky cervical cancer is a feasible option. The disadvantage is the potential increase in treatment complications. Chemoradiation without brachytherapy followed by surgery has been found to have equivalent outcomes and is associated with acceptable morbidity.
CONCLUSIONS: In resource-constrained settings where brachytherapy is not available, performing radical hysterectomy after chemoradiation therapy without brachytherapy has been shown to produce equivalent outcomes. It seems reasonable to adopt a modified therapeutic protocol of chemoradiation followed by extrafascial hysterectomy as an alternative treatment option in low-resource countries where brachytherapy is not readily available.

Entities:  

Mesh:

Year:  2016        PMID: 26398064     DOI: 10.1097/COC.0000000000000222

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  4 in total

1.  Long-Term Results of Concurrent Chemoradiotherapy Combined with Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single-Institute Prospective Study.

Authors:  Defeng Qing; Yuying Wu; Xu Liu; Hailan Jiang; Chaohua Zhu; Pei Liu; Junming Dang; Xianglong Li; Zhaohong Chen; Xianfeng Long; Qiang Pang; Luxing Peng; Shan Deng; Junzhao Gu; Renfeng Zhao; Changyi Chen; Heming Lu
Journal:  Cancer Manag Res       Date:  2020-12-01       Impact factor: 3.989

Review 2.  Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges.

Authors:  Carolyn Johnston; Joseph S Ng; Ranjit Manchanda; Audrey Tieko Tsunoda; Linus Chuang
Journal:  Gynecol Oncol Rep       Date:  2017-01-09

3.  Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer.

Authors:  Li-Chun Wei; Xin Li; Ying Zhang; Yun-Zhi Dang; Wei-Wei Li; Jian-Ping Li; Li-Na Zhao; Shu-Juan Liu; Xia Li; Mei Shi
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

4.  Cervical cancer screening and treatment capacity: A survey of members of the African Organisation for Research and Training in Cancer (AORTIC).

Authors:  Linus Chuang; Nicole Rainville; Maureen Byrne; Thomas Randall; Kathleen Schmeler
Journal:  Gynecol Oncol Rep       Date:  2021-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.